Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Makoto Endo"'
Autor:
Takeshi Hirose, Shinji Kohsaka, Hiroyuki Mano, Masachika Ikegami, Yoshihiro Matsumoto, Yasuharu Nakashima, Makoto Endo
Publikováno v:
Lung Cancer. 152:135-142
Objectives Exon 20 insertion mutations of epidermal growth factor receptor (EGFR) have been identified as oncogenic mutations in general; however, the functional relevance of each remains largely uninvestigated. Herein, we comprehensively assessed th
Autor:
Tom Wei-Wu Chen, Herbert H. Loong, Sze Huey Tan, Alex K.C. Leung, Richard Quek, Chih Chi Chang, Angela Pang, Myo Myint Maw, Takeshi Hirose, Makoto Endo, Akira Kawai, Mark E. Puhaindran, Virote Sriuranpong, Siyamol Mingmalairak, Mohamad Farid, Jeffrey C.H. Chan, Wei Lin Goh, Roger K.C. Ngan
Publikováno v:
Cancer Science
Angiosarcoma (AS) is a rare disease with a dismal prognosis. The treatment landscape and prognostic factors for advanced AS, including locally advanced, unresectable, and metastatic disease remain elusive. The Asian Sarcoma Consortium is an internati
Publikováno v:
Expert Review of Anticancer Therapy. 20:893-900
Soft-tissue sarcoma (STS) denotes a group of rare and highly heterogeneous malignant tumors of mesenchymal origin. Accurate histological diagnosis is critical for selecting appropriate treatment. Complete tumor resection is the primary treatment for
Publikováno v:
J Thorac Dis
BACKGROUND: Spread through air spaces (STAS) is reportedly a significant risk factor for recurrence and a prognostic factor in patients with non-small cell lung cancer (NSCLC), especially after sublobar resection. Because wedge resection (WR) is asso
Autor:
Hiroaki Hiraga, Makoto Endo, Takafumi Ueda, Akihiko Matsumine, Toru Hiruma, Nobuhito Araki, Hideo Morioka, Tsukasa Yonemoto, Toshiyuki Kunisada, Kazato Goda, Shunji Takahashi, Akira Kawai, Hideshi Sugiura, Mitsuru Takahashi
Publikováno v:
Cancer Medicine, Vol 9, Iss 11, Pp 3656-3667 (2020)
Cancer Medicine
Cancer Medicine
The time course of the response to each drug is important to avoid inappropriate termination of treatment by misjudging tumor progression; however, little is known about soft tissue sarcoma (STS) regarding this matter. This study aimed to perform a t
Autor:
Yoshihiro Matsumoto, Kenichiro Yahiro, Toshifumi Fujiwara, Yasuharu Nakashima, Atsushi Kimura, Nokitaka Setsu, Eijiro Shimada, Makoto Endo
Publikováno v:
Japanese journal of clinical oncology. 51(8)
Background Soft tissue sarcomas arise in the deep sites of the buttocks and lower extremities. Since a tourniquet is not applied during surgery for soft tissue sarcomas at such sites, excessive intraoperative blood loss may occur. Various devices, in
Autor:
Akira Kawai, Nobuhiko Yokoyama, Suguru Fukushima, Yasuharu Nakashima, Fumihiko Nakatani, Tomoyoshi Soga, Yukiko Aikawa, Atsushi Kimura, Ayuna Hattori, Makoto Nakagawa, Takahiko Seki, Takeshi Hirose, Yoko Ogawara, Kazutsune Yamagata, Makoto Endo, Kenichiro Yahiro, Issay Kitabayashi, Yukihide Iwamoto, Hironori Matsunaga, Shuhei Fujita, Takamasa Ishikawa, Toshifumi Fujiwara, Yukino Machida, Eijiro Shimada, Yoshihiro Matsumoto, Hirokazu Chuman, Nokitaka Setsu, Takuo Katsumoto
Publikováno v:
Oncogene. 38:6835-6849
Chondrosarcoma is the second most common malignant bone tumor. It is characterized by low vascularity and an abundant extracellular matrix, which confer these tumors resistance to chemotherapy and radiotherapy. There are currently no effective treatm
Autor:
Eisuke Kobayashi, Makoto Endo, Aiko Maejima, Yoichi Naito, Yasunori Megumi, Shunji Takahashi, Akira Kawai, Naofumi Asano
Publikováno v:
Japanese Journal of Clinical Oncology
Interim analysis from the first large-scale post-marketing surveillance study of eribulin treatment for soft tissue sarcomas (STSs) showed antitumor activity in both common and rare subtypes of STS (NCT03058406).
Background Although eribulin is
Background Although eribulin is
Autor:
Seiji Okada, Yoshihiro Matsumoto, Satoshi Nomoto, Makoto Endo, Nokitaka Setsu, Shingo Baba, Hirokazu Saiwai, Kenichi Kawaguchi, Toshifumi Fujiwara, Mistumasa Hayashida, Keiichiro Iida, Yasuharu Nakashima, Akira Matsunobu
Publikováno v:
International Journal of Clinical Oncology. 24:1490-1497
To evaluate the clinical outcome of combination of carbon-ion radiotherapy with separation surgery (CIRT-SS) in patients with primary spinal/paraspinal sarcoma (PSPS) and epidural spinal cord compression (ESCC). CIRT-SS was performed in 11 consecutiv
Autor:
Kenichi Kohashi, Yoshihiro Matsumoto, Yasuharu Nakashima, Shinichiro Kawatoko, Hidetaka Yamamoto, Izumi Kinoshita, Kengo Kawaguchi, Toshifumi Fujiwara, Makoto Endo, Nokitaka Setsu, Shin Ishihara, Yu Toda, Daisuke Kiyozawa, Yousuke Susuki, Takeshi Iwasaki, Dai Takamatsu, Taro Mori, Yuichi Yamada, Yoshihiro Ito, Yoshinao Oda
Publikováno v:
Journal of cancer research and clinical oncology. 147(7)
Undifferentiated pleomorphic sarcoma (UPS) is a sarcoma with a poor prognosis. A clinical trial, SARC028, revealed that treatment with anti-PD-1 drugs was effective against UPS. Studies have reported that UPS expresses PD-L1, sometimes strongly (≥